NCT01692886 - A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China | Biotech Hunter

Enrollment

1,674

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL

7-valent Pneumococcal Conjugate Vaccine

suspension in prefilled syringe for intramuscular injection; 0.5 mL; one dose at 3-Month Visit, 4-Month Visit, 5-Month Visit, and 12-Month Visit, respectively

BIOLOGICAL

13-valent Pnumococcal Conjugate vaccine

suspension in prefilled syringe for intramuscular injection; 0.5 mL; one dose at 3-Month Visit, 4-Month Visit, 5-Month Visit, and 12-Month Visit, respectively

BIOLOGICAL

13-valent Pnumococcal Conjugate vaccine

suspension in prefilled syringe for intramuscular injection; 0.5 mL; one dose at 2-Month Visit, 4-Month Visit, 6-Month Visit, and 12-Month Visit, respectively

BIOLOGICAL

13-valent Pnumococcal Conjugate vaccine

suspension in prefilled syringe for intramuscular injection; 0.5 mL; one dose at 3-Month Visit, 5-Month Visit, and 12-Month Visit, respectively

Trial Locations (4)

222200

Jiangsu Province Guanyun County Center for Disease prevention and Control, Guanyun County,

223100

Jiangsu Province Hongze County Center for Disease prevention and Control, Huaian City

223300

Jiangsu Province Huaiyin District Center for Disease prevention and Control, Huaian City

223400

Jiangsu Province Lianshui County Center for Disease prevention and Control, Lianshui County